Sign In
Manage PermissionsManage Permissions

Four Health Products Found Adultrated


The Ministry of Health would like to alert members of the public to four types of health products which have been tested by the Pharmacy Laboratory Services, Laboratory Services, Ministry of Health and found to be adulterated with undeclared, potent western medicine.

                                        

The affected health products are listed as below:

No.Name of productManufacturerAdulterated with
1.X-Stive Men 400M 400mg Capsule

Stive Health Inc,

U.S.A

Sildenafil
2.AL-Barakah Ayam Selasih PilKampung Gulau, Mukim Sok, Slk, KedahDexamethasone
3.Pee Pa Wan PillNot StatedChlorpheniramine
4.Slimming Booster Capsule 350mgNot StatedSibutramine & Phenolphthalein

 

CLICK HERE FOR THE IMAGE

The adulterant found in this product can cause adverse effects that are potentially hazardous to the people using them.

 

Sildenafil is a drug used to treat male impotency and can only be prescribed by a qualified doctor or physician. Among their side effects include nausea, vomiting, flushing and dizziness. In severe cases, they can also result in abnormal increase in heart rate, sudden loss of hearing and seizures.

 

Unsupervised long-term consumption of potent corticosteroids such as Dexamethasone can cause increase blood glucose levels leading to diabetes, high blood pressure, cataracts, muscular and bone disorders, and an increased risk of infections. Long term use of corticosteroids can also lead to Cushing's syndrome which is characterized by a round face or 'moon face', and upper body obesity with thin limbs. Consumers who have taken high doses of steroids over a prolonged period of time may suffer from withdrawal symptoms which include fatigue, muscle and joint pain, fever, low blood sugar, low blood pressure and dehydration.

 

Dizziness, lowering of blood pressure, irregular hearbeat, confusion, depression and convulsions are among the adverse effects that could occur from the unsupervised consumption of Chlorpheniramine.

 

Sibutramine is a slimming agent and is no longer recommended for medical use in obesity due to its harmful effects on the heart and liver. Its consumption can also cause serious adverse reactions such as high blood pressure, heart palpitation, insomnia and in worst cases, kidney and liver damage.

 

 

Prolonged consumption or overdose of Phenolphthalein can result in diarrhoea with excessive loss of water and electrolytes, and there is also the possibility of developing an atonic non-functioning colon. Cardiac and respiratory distress, renal damage and hypersensitivity reactions have also been reported with the use of this drug.

 

The Ministry of Health has not issued any approval for the importation for the sale of these products. Following these findings, the products are not allowed to be imported and sold in Brunei Darussalam.

 

Members of the public who have purchased or used these products are advised to stop using them immediately. They should also consult a medical practitioner if they feel unwell or experience any undesirable reactions as a result of using them.

 

Members of the public involved in the retail of these products (including online retail such as through Facebook, etc.) are hereby reminded that it is an offence under the Poisons Act 1956 to sell any product containing any substance controlled under the said Act and the penalty for such an offence upon conviction, is a fine of $8,000 or six months' imprisonment. Furthermore, if a person commits an Act that amounts to such a degree of negligence so as to endanger or be likely to endanger human life, then such person shall be guilty of an offence which carries a penalty of a fine of $16,000 and 12 months' imprisonment.

 

The Ministry of Health would also like to call upon the public for their cooperation to report to the Health Regulations Services if any of these products are still found on the market in this country.

 

For further information and communication, the public may contact the Health Regulations Services at 2384182, send an e-mail to health.regulations@moh.gov.bn or go directly to Health Regulations Services, 1st Floor, Ministry of Health, Commonwealth Drive, Brunei Darussalam.


 E N D  -

 

Reference       : KK/PR/3

Date                : 11 July 2017 / 16 Syawal 1438


Attachments